Clinical Trials Logo

Filter by:
NCT ID: NCT04591847 Completed - Clinical trials for Pregnancy Outcome Among Vitamin D Supplementation During Pregnancy

Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy

Start date: October 19, 2020
Phase: Phase 3
Study type: Interventional

To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo

NCT ID: NCT04582929 Completed - Cervical Dystonia Clinical Trials

Neubotulinum Toxin Injection in Cerivical Dystonia

NTCD
Start date: January 3, 2019
Phase: Phase 3
Study type: Interventional

24-Week Prospective, Double-Blinded, Randomized, Cross-over design in Multicenter Study of 50 unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A (Neuronox) injection for Cervical Dystonia in patient diagnosed with cervical dystonia according to clinical diagnosis. It was designed to evaluate the efficacy, safety, tolerability, quality of life and the comparesion the improvement after treatment by of 50 unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A (Neuronox) injection.

NCT ID: NCT04578080 Completed - Stroke, Acute Clinical Trials

Effect of tDCS on Motor Functions and Brain Activity in Acute Stroke Patients

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of anodal tDCS combined with conventional physical therapy for 5 consecutive sessions on motor functions and brain activity in acute stroke patients at immediate and 1-month follow-up.

NCT ID: NCT04577287 Completed - Stroke, Acute Clinical Trials

The Effects of Anodal and Cathodal tDCS Combined With Conventional Physical Therapy in Patients With Acute Stroke

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The objective of the study is thus to compare the effects 5 consecutive sessions of anodal and cathodal tDCS combined with conventional physical therapy on upper and lower limb motor performance in acute stroke at immediate, and 1-month followup.

NCT ID: NCT04577274 Completed - Clinical trials for Diabetes Mellitus, Type 2

Impact of High Protein and Low Carbohydrate Smoothie Drinks in Type-2 Diabetes Mellitus

Start date: November 4, 2020
Phase: N/A
Study type: Interventional

We compared between a regular high protein or a high protein and low carbohydrate smoothie drinks with conventional diabetic enteral drinks (Glucerna) on glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals.

NCT ID: NCT04572672 Completed - Clinical trials for Hypertensive Urgency

Effect of Pursed-Lip Breathing on Blood Pressure and Heart Rate

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Hypertensive urgency (HT urgency) is an alarm sign of uncontrolled hypertension. It can be aggravated by nonadherent to medication and psychosocial stress. Mindfulness is beneficial for reducing stress, while deep and slow breathing is effective for blood pressure (BP) lowering. The objective of the study was to assess the effect of pursed-lip breathing with number counting (PLB with NC) that promotes mindfulness and a deep/slow breathing pattern on BP and heart rate (HR) in the HT urgency patients.

NCT ID: NCT04568512 Completed - Cholangiocarcinoma Clinical Trials

DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture

DNA
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

DNA methylation biomarker for diagnosis of cholangiocarcinoma in patients with bile duct stricture has high sensitivity and specificity compared with cytology from the brush specimens

NCT ID: NCT04566276 Completed - Safety Issues Clinical Trials

ChulaCov19 Vaccine in Healthy Adults

Start date: May 3, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study will be conducted in 2 phases. Phase 1 of this study will be a single-centre, open label, dose escalation first in human (FIH) study conducted in 2 groups of healthy participants. Group 1 will enrol adults aged 18-55 years (inclusive); Group 2 will enroll elderly adults (elderly) aged 56-75 years (inclusive). Phase 2 of this study will be a single centre, the proposed design will be observer-blind, placebo-controlled study to assess the safety, reactogenicity, and immunogenicity of ChulaCov19 vaccine in healthy adults (18-75 years of age inclusive).

NCT ID: NCT04560218 Completed - Clinical trials for To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women

Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

Start date: October 30, 2020
Phase: Phase 3
Study type: Interventional

Research Objective: Primary outcome -To compare efficacy Intrauterine vs Sublingual MISOPROSTOL in addition to Oxytocin in reducing blood loss of post-cesarean section in high risk women Secondary outcome -To study Hemoglobin/Hematocrit change, need of uterotonic agents, need of blood transfusion, adverse drug event of Intrauterine vs Sublingual Misoprostol plus Oxytocin compare to Oxytocin alone Hypothesis: -Intrauterine MISOPROSTOL plus Oxytocin is not inferior to Sublingual MISOPROSTOL plus Oxytocin in reducing blood loss of post-cesarean section in high risk women

NCT ID: NCT04530851 Completed - Clinical trials for To Determine Whether ERAS Can Reduce Length of Stay in Pregnant Women After Cesarean Section

Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

Research objective to compare outcome(Length of stay, pain score, opioid drug use, Bowel function and complication ) of ERAS protocol and conventional care in pregnant women after elective cesarean section in Rajavithi hospital.